Connect with us


The Capitalist Newsletter – December 20, 2016



OVERSTOCK LAUNCHES TØ PLATFORM; BEGINS TRADING SHARES VIA BITCOIN BLOCKCHAIN’s CEO Patrick Byrne has been a champion of bitcoin since the digital currency came about. But now he’s really putting his (digital) money where his mouth is. On Monday, Byrne and his team became the first publicly traded company to issue stock over the internet using a subsidiary created by Byrne and his team powered by the bitcoin blockchain. Why is this such a big deal? Is trading about to change? What can we expect from Overstock?

Read The Capitalist’s Take Here

Read More at Wired

Read More at Forbes


Top executives of New York-based hedge fund manager Platinum Partners were arrested on Monday and charged with running an approximately $1 billion fraud that federal prosecutors said became “like a Ponzi scheme” as its largest investments lost much of their value..

Read More at Fortune Here

Read More at USA Today Here

Read More at Wall Street Journal Here


Rogue One: A Star Wars Story has pushed Walt Disney Studios to rare planetary air: It's the first studio to take in more than $7 billion at the box office globally. After the weekend's box office grosses, including a $290 million global debut for Rogue One, Disney had hit $6.998 billion for the year — $2.7 billion in the U.S. and nearly $4.3 billion internationally, the studio said Monday..

Read More at USA Today Here

Read More at Deadline Here

Read More at Forbes Here

Closing Bell

– Monday, December 19th

Markets Edge Higher Led by Tech

Big Insider Trades

– Host Hotels & Resorts, Inc. (HST) CEO Edward Walter Sells $2.5m

-Achaogen, Inc. (AKAO) Stake Owner Peter Sonsini Buys $6.75m

Winners & Losers

– Loxo Oncology, Inc. (LOXO) Soars UP (25.83%) After Seeing 85% Enrollment of Company’s Goal for Mid Stage Trials and Revealing Four Product Candidates in Company’s Pipeline Aimed at Treating Genetically Defined Cancers

– Jakks Pacific, Inc. Tanks DOWN (32.62%) After Drastic Outlook Cut

Most Talked About

Clovis Oncology, Inc. (CLVS) a Majority Strong Buy After Receiving Early FDA Approval for Advanced Cancer Drug

The TIP Sheets

– Monday, December 19th

– Clovis Oncology, Inc. (CLVS) a Spikes UP (8.82%) After Receiving Early FDA Approval by 3 Months for Advanced Ovarian Cancer Drug. Expect Shares to Continue UP

Unusual Volume

– Globalstar, Inc. (GSAT) Leaps UP (28.57%) on 38m Shares Traded After FCC is Reportedly Set to Consider New Proposal From Company Following Previous Plan Being Shot Down. Look For Shares to Continue UP

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Continue Reading

Copyright © 2023 The Capitalist. his copyrighted material may not be republished without express permission. The information presented here is for general educational purposes only. MATERIAL CONNECTION DISCLOSURE: You should assume that this website has an affiliate relationship and/or another material connection to the persons or businesses mentioned in or linked to from this page and may receive commissions from purchases you make on subsequent web sites. You should not rely solely on information contained in this email to evaluate the product or service being endorsed. Always exercise due diligence before purchasing any product or service. This website contains advertisements.

Is THE newsletter for…


Stay up-to-date with the latest kick-ass interviews, podcasts, and more as we cover a wide range of topics, in the world of finance and technology. Don't miss out on our exclusive content featuring expert opinions and market insights delivered to your inbox 100% FREE!